
Egetis Therapeutics AB (publ)
SSE:EGTX.ST
6.07 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||
Current Assets: | |||||||||||||||||
Cash & Cash Equivalents
| 351 | 303.3 | 127.7 | 143.965 | 287.85 | 255.101 | 229.876 | 309.531 | 393.998 | 50.36 | 100.043 | 49.302 | 58.808 | 90.548 | 0.568 | 0.38 | 0.717 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 351 | 303.3 | 127.7 | 143.965 | 287.85 | 255.101 | 229.876 | 309.531 | 393.998 | 50.36 | 100.043 | 49.302 | 58.808 | 90.548 | 0.568 | 0.38 | 0.717 |
Net Receivables
| 23.6 | 28.2 | 10.2 | 6.795 | 6.843 | 5.2 | 10.068 | 4.001 | 1.602 | 0.963 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 1 | 0.7 | 0.6 | 0.694 | 3.138 | 0 | 2.092 | 0 | -1.602 | -0.963 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0 | 13.7 | 15.3 | 1.448 | 5 | 9.649 | 3.23 | 3.271 | 2.695 | 2.001 | 3.162 | 1.654 | 1.591 | 0.865 | 0.229 | 0.081 | 0 |
Total Current Assets
| 380.1 | 345.9 | 147.4 | 152.902 | 299.871 | 269.95 | 242.037 | 315.368 | 396.435 | 52.361 | 103.416 | 50.956 | 60.399 | 91.413 | 0.797 | 0.462 | 0.824 |
Non-Current Assets: | |||||||||||||||||
Property, Plant & Equipment, Net
| 2.6 | 4.4 | 2.7 | 4.274 | 4.741 | 0.123 | 0 | 0 | 0 | 0.001 | 0.003 | 0.005 | 0.008 | 0.012 | 0.004 | 0.007 | 0.009 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 408 | 409.1 | 410.3 | 411.307 | 589.356 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.691 | 0 | 0 |
Goodwill and Intangible Assets
| 408 | 409.1 | 410.3 | 411.307 | 589.356 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.691 | 5.446 | 4.539 |
Long Term Investments
| 0.8 | 0.8 | 0.8 | 0.785 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 0.05 | 0 | 0 | 0 | 0 |
Tax Assets
| 0.6 | -0.7 | -0.8 | -0.785 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 1 | 0 | 0.7 | 0.785 | 0 | -0.123 | 0 | 0 | 0 | -0.001 | 0.049 | 0 | -0.001 | 0 | 0 | 0 | 0 |
Total Non-Current Assets
| 412.2 | 414.3 | 413.7 | 416.366 | 594.097 | 0.123 | 0 | 0 | 0 | 0 | 0.052 | 0.055 | 0.057 | 0.012 | 7.695 | 5.453 | 4.547 |
Total Assets
| 792.3 | 760.2 | 561.1 | 569.268 | 893.967 | 270.073 | 242.037 | 315.368 | 396.435 | 52.361 | 103.468 | 51.011 | 60.457 | 91.425 | 8.492 | 5.914 | 5.371 |
Liabilities & Equity: | |||||||||||||||||
Current Liabilities: | |||||||||||||||||
Account Payables
| 25.7 | 28.7 | 20 | 4.6 | 15.611 | 11.207 | 15.174 | 5.972 | 4.678 | 1.766 | 9.967 | 1.278 | 2.331 | 1.432 | 1.021 | 0.15 | 0.179 |
Short Term Debt
| 30.1 | 7.4 | 1.6 | 1.5 | -38.847 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Payables
| 0.2 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.132 | 0.043 | 0.018 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 39.988 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 148.2 | 67.7 | 27.8 | 33.07 | 13.401 | 13.873 | 7.501 | 5.685 | 2.453 | 2.563 | 2.843 | 2.779 | 4.185 | 2.329 | 0.439 | 0.105 | 0.144 |
Total Current Liabilities
| 204.2 | 103.9 | 49.4 | 39.17 | 70.141 | 25.081 | 22.675 | 11.657 | 6.874 | 4.329 | 12.81 | 4.057 | 6.516 | 3.893 | 1.502 | 0.274 | 0.324 |
Non-Current Liabilities: | |||||||||||||||||
Long Term Debt
| 84.1 | 105.6 | 1.1 | 2.7 | -174.537 | 0.117 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0.109 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0.5 | 0 | 0 | 0 | 119.847 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 10.6 | 5.1 | 4.4 | 0.36 | -107.346 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 95.2 | 110.7 | 5.5 | 3.06 | 194.199 | 0.116 | 0 | 0 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities
| 299.4 | 214.6 | 54.9 | 42.23 | 264.34 | 25.197 | 22.675 | 11.657 | 6.873 | 4.329 | 12.81 | 4.057 | 6.516 | 3.893 | 1.502 | 0.274 | 0.324 |
Equity: | |||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 20.4 | 15.4 | 11.3 | 8.688 | 8.688 | 2.818 | 2.561 | 2.561 | 2.561 | 1.494 | 1.492 | 1.154 | 1.066 | 1.066 | 0.301 | 0.233 | 0.207 |
Retained Earnings
| -1,610.1 | -1,266.5 | -939.6 | -745.792 | -642.346 | -463.22 | -401.797 | -316.794 | -38.223 | -43.836 | -48.42 | -25.549 | -33.857 | -33.246 | -3.801 | -2.195 | -0.849 |
Accumulated Other Comprehensive Income/Loss
| 0 | 16.7 | 6.1 | 1.305 | 0.448 | 0 | 0.001 | 0 | 0 | 0 | -0 | 0.001 | 0 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 2,082.5 | 1,780 | 1,428.4 | 1,262.838 | 1,262.837 | 705.278 | 618.597 | 617.944 | 615.861 | 90.374 | 137.586 | 71.348 | 86.732 | 119.712 | 10.489 | 7.603 | 5.69 |
Total Shareholders Equity
| 492.8 | 545.6 | 506.2 | 527.038 | 629.627 | 244.876 | 219.361 | 303.711 | 389.562 | 48.032 | 90.658 | 46.953 | 53.941 | 87.532 | 6.99 | 5.641 | 5.047 |
Total Equity
| 492.8 | 545.6 | 506.2 | 527.038 | 629.627 | 244.876 | 219.361 | 303.711 | 389.562 | 48.032 | 90.658 | 46.953 | 53.941 | 87.532 | 6.99 | 5.641 | 5.047 |
Total Liabilities & Shareholders Equity
| 792.2 | 760.2 | 561.1 | 569.268 | 893.967 | 270.073 | 242.036 | 315.368 | 396.435 | 52.361 | 103.468 | 51.01 | 60.457 | 91.425 | 8.492 | 5.914 | 5.371 |